Related Experiment Video
Updated: Jun 8, 2026
08:44
Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Clinical study on pulmonary diffusion function in patients with chronic liver disease
Yan Miao Huo1, Rong Hua, Wei Chen
1Department of General Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, China.
Journal of Digestive Diseases
|October 2, 2010
Summary
Chronic liver disease (CLD) impairs pulmonary diffusion. The study found reduced pulmonary diffusion capacity for carbon monoxide (DLCO) with worsening liver dysfunction, highlighting MELD score
Area of Science:
- Pulmonary Medicine
- Hepatology
- Cardiovascular Imaging
Background:
- Chronic liver disease (CLD) can lead to significant systemic complications.
- Pulmonary vascular abnormalities are increasingly recognized in patients with CLD.
Purpose of the Study:
- To investigate the impact of chronic liver disease severity on pulmonary diffusion function.
- To evaluate the utility of different scoring systems in assessing these pulmonary changes.
Main Methods:
- Fifty cirrhotic patients underwent arterial blood gas analysis, pulmonary function tests, and echocardiography.
- Chronic liver disease severity was assessed using Child-Pugh-Turcotte (CPT) and Model for End-Stage Liver Disease (MELD) scores.
Main Results:
- Increased alveolar-arterial oxygen gradient (A-aDO2) correlated with liver dysfunction severity (CPT and MELD scores).
- Pulmonary diffusion capacity for carbon monoxide (DLCO) significantly decreased with increasing CPT and MELD scores.
- DLCO showed a negative correlation with both CPT (r=-0.630) and MELD (r=-0.708) scores.
Conclusions:
- Pulmonary diffusion capacity for carbon monoxide (DLCO) is a valuable indicator for detecting pulmonary vascular abnormalities in CLD patients.
- The MELD score may serve as a more accurate predictor of intrapulmonary vascular damage in CLD compared to the CPT score.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:17Assessment of Diffusion and Perfusion
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...